These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16716112)

  • 1. CD46 represents a target for adenoviral gene therapy of malignant glioma.
    Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
    Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
    Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
    J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
    Tyler MA; Ulasov IV; Borovjagin A; Sonabend AM; Khramtsov A; Han Y; Dent P; Fisher PB; Curiel DT; Lesniak MS
    Mol Cancer Ther; 2006 Sep; 5(9):2408-16. PubMed ID: 16985075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
    Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
    Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
    Ulasov IV; Tyler MA; Han Y; Glasgow JN; Lesniak MS
    Hum Gene Ther; 2007 Feb; 18(2):118-29. PubMed ID: 17328684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
    Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
    J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
    Takayama K; Reynolds PN; Short JJ; Kawakami Y; Adachi Y; Glasgow JN; Rots MG; Krasnykh V; Douglas JT; Curiel DT
    Virology; 2003 May; 309(2):282-93. PubMed ID: 12758175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
    Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
    Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
    Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
    Toivonen R; Suominen E; Grenman R; Savontaus M
    Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
    Ni S; Gaggar A; Di Paolo N; Li ZY; Liu Y; Strauss R; Sova P; Morihara J; Feng Q; Kiviat N; Touré P; Sow PS; Lieber A
    Cancer Gene Ther; 2006 Dec; 13(12):1072-81. PubMed ID: 16874361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T; Sato K; Hamada H
    Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.